Bio Impact Capital LLC Replimune Group, Inc. Transaction History
Bio Impact Capital LLC
- $511 Million
- Q2 2025
A detailed history of Bio Impact Capital LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 983,780 shares of REPL stock, worth $5.16 Million. This represents 1.79% of its overall portfolio holdings.
Number of Shares
983,780
Previous 987,036
0.33%
Holding current value
$5.16 Million
Previous $9.62 Million
5.03%
% of portfolio
1.79%
Previous 1.78%
Shares
3 transactions
Others Institutions Holding REPL
# of Institutions
176Shares Held
78MCall Options Held
219KPut Options Held
216K-
Baker Bros. Advisors LP New York, NY11MShares$58 Million1.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$56.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$24.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.66MShares$24.5 Million5.27% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$20.5 Million9.84% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $259M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...